论文部分内容阅读
目的:观察代温灸膏天灸对儿童哮喘控制水平的影响。方法:将60例儿童哮喘发作期的患儿随机分为治疗组和对照组。治疗组在农历三九、三伏天用代温灸膏贴敷背部穴位,对照组不施加天灸治疗,2组均吸入沙美特罗替卡松干粉剂。观察1年治疗期间儿童哮喘控制测试(C-ACT)评分、晨间最大呼气峰流速值(PEFam)的变化。结果:2组患儿经治疗3月、6月、12月C-ACT评分与治疗前比较,差异均有非常显著性意义(P<0.01)。治疗组治疗3月、6月分别与对照组比较,差异均有显著性意义(P<0.05)。2组患儿治疗3月、6月、12月PEFam%分别与本组治疗前比较,差异均有非常显著性意义(P<0.01)。经治疗12月,2组患儿全部C-ACT评分达到哮喘完全控制,吸入舒利迭每天1泡达到完全控制的例数治疗组多于对照组,2组比较,差异有显著性意义(P<0.05)。结论:用代温灸膏天灸治疗能够提高儿童哮喘的控制水平,减少吸入性糖皮质激素(ICS)的用量。
Objective: To observe the effects of moxibustion on behalf of day moxibustion on children with asthma control. Methods: Sixty children with childhood asthma attack were randomly divided into treatment group and control group. The treatment group in the lunar calendar three or three days of day with moxibustion on behalf of the Ministry of acupuncture sticking acupressure points, the control group did not impose days of moxibustion treatment, both groups were inhaled salmeterramidine rosiglitazone dry powder. The changes of C-ACT score and peak morning expiratory flow rate (PEFam) in one-year treatment were observed. Results: There was significant difference in C-ACT score between the two groups in March, June and December after treatment (P <0.01). The treatment group in March and June were compared with the control group, the difference was significant (P <0.05). The difference of PEFam% in 3 months, 6 months and 12 months before and after treatment in both groups was significant (P <0.01). After treatment for 12 months, all C-ACT scores of the two groups reached complete control of asthma, and the number of cases in which inhaled sedaparin reached full control was more in the treatment group than in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Day moxibustion cream moxibustion treatment can improve the control of children with asthma and reduce the amount of inhaled glucocorticoid (ICS).